Although disruption of the p53 occurs in a subset of HCC, more than half of tumors retain a wild-type p53, suggesting that alteration of other molecules involved in this pathway might also contribute to hepatocarcinogenesis [4]. This evidence concerns the gene TP53 and hepatocellular carcinoma.